XXE97U7Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7

New Technology›Physiological Systems›Measurement
  • Billable / Specific Code
ICD-10-PCS XXE97U7
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XXE97U7 is a billable ICD-10-PCS procedure code for Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Measurement involves determining the level of a physiological or physical function at a point in time. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Measurement and monitoring, NEC.

Code Identity

ICD-10-PCS Code
XXE97U7
Billable Status
Yes — Valid for Submission
Code Describes
Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7
Short Description
Measurement of Nasophrn Fluid SARS-CoV-2 PCR, New Tech 7
Parent Code
XXE

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemXPhysiological Systems
3OperationEMeasurement
4BodyPart9Nose
5Approach7Via Natural or Artificial Opening
6Device/Substance/TechnologyUInfection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction
7Qualifier7New Technology Group 7

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

ISC-REST kit, QIAstat-Dx Respiratory SARS-CoV-2 Panel
Direct entry for this code
SARS-CoV-2 Polymerase Chain Reaction, Nasopharyngeal Fluid
Direct entry for this code
New Technology, SARS-CoV-2 Polymerase Chain Reaction, Nasopharyngeal Fluid
Direct entry for this code

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

MAM015
Measurement and monitoring, NEC
Clinical domain: Measurement and Monitoring

Questions About XXE97U7

Is XXE97U7 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in XXE97U7 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character E is the Operation (Measurement); the 4th character 9 is the BodyPart (Nose); the 5th character 7 is the Approach (Via Natural or Artificial Opening); the 6th character U is the Device/Substance/Technology (Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction); the 7th character 7 is the Qualifier (New Technology Group 7).